Scientists identify gene vital for rebuilding intestine after cance...
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Category: Gastroenterology
UNC-Duke collaboration probes the depths of gut health
UNC stem cell expert Scott Magness, PhD, and Duke microbiome researcher John Rawls, PhD, are using a $50,000 grant to develop a new technology to study the co-dependent relationship between the human gut and its resident bacteria.
Another breastfeeding benefit: preparing baby’s belly for solid food
A close examination of gut bacteria reveals that exclusively breastfed babies are better equipped for the transition to solids and potentially an early life with fewer stomach woes
Adults with Eosinophilic Esophagitis Should Consider a Diet Change
By eliminating specific foods from patients’ diets, symptoms improved in 71 percent of patients.
A Path Divergent
Five Questions for Robert Sandler, a world-renowned gastroenterologist who has challenged a major theory about the cause of diverticulosis.
Expected decline in liver transplants due to lower quality donor liver
A study led by Eric S. Orman, MD, published in the January 2013 issue of the journal Liver Transplantation, found that the non-use of donor livers climbed through 2010 due to a worsening of donor liver quality, primarily from donation following cardiac death.
Gut microbes help the body extract more calories from food
You may think you have your food all to yourself, but you’re actually sharing it with a vast community of microbes waiting within your digestive tract.
Diets high in fiber won’t protect against diverticulosis
For more than 40 years, scientists and physicians have thought eating a high-fiber diet lowered a person’s risk of diverticulosis, a disease of the large intestine in which pouches develop in the colon wall.
Rifaximin provides significant relief of irritable bowel syndrome s...
Two studies, conducted in part at the UNC School of Medicine, found that the benefits of treatment with rifaximin persisted for 10 weeks after patients stopped taking the broad-spectrum antibiotic.